⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of IngeniumAI and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
IngeniumAI
↗Bath, United Kingdom
IngeniumAI is a UK-based MedTech company that develops software integrated within healthcare systems to assist clinicians in diagnosing diseases more quickly using routinely collected medical scans. By leveraging machine learning, the company aims to reduce the time to diagnosis from years to weeks, thereby improving patient safety and alleviating the burden on healthcare systems.
The company operates at the intersection of clinical expertise and machine learning. Their technology automatically analyzes clinical tests and scans to flag potential signs of disease that might otherwise be missed, facilitating earlier intervention and treatment.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Medical Imaging / Diagnostics AI
SIZE & FINANCIALS
Employees:1-50
Ownership:private
Status:operating
FUNDING
Stage:Seed
Total Raised:$0.3M
Investors:Innovate UK
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A
Modalities:AI/Software as a Medical Device (SaMD)
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:NHS (Clinical studies)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Jeff Clark - Co-founder & Chief Executive Officer
Jay Suntharalingam - Co-founder & Lead Physician
Andrew Cookson - Co-founder & Chief Scientific Officer
Scientific Founders:Jay Suntharalingam, Jeff Clark, Andrew Cookson
LINKS
Website:ingeniumai.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with IngeniumAI. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.